Azithromycin Dosing for Lower Respiratory Tract Infection in a 60-kg Child
For a 60-kg child with community-acquired pneumonia, administer azithromycin 500 mg (10 mg/kg) on day 1, followed by 250 mg (5 mg/kg) once daily on days 2 through 5.
Recommended Dosing Regimen
The standard pediatric dosing for community-acquired pneumonia is weight-based, but doses should not exceed adult doses 1. For this 60-kg child:
- Day 1: 500 mg (maximum adult dose, rather than calculated 600 mg)
- Days 2-5: 250 mg once daily (maximum adult dose, rather than calculated 300 mg)
This follows the FDA-approved 5-day regimen specifically indicated for community-acquired pneumonia 2.
Pathogen-Specific Considerations
The 2011 PIDS/IDSA guidelines provide clear pathogen-directed dosing 1:
For Atypical Pathogens (Mycoplasma, Chlamydia)
- Preferred oral therapy: Azithromycin 10 mg/kg day 1, then 5 mg/kg days 2-5
- Alternative: Clarithromycin 15 mg/kg/day in 2 doses or erythromycin 40 mg/kg/day in 4 doses
- For children >7 years: Doxycycline 2-4 mg/kg/day in 2 doses
For Bacterial Pneumonia
If the clinical picture suggests typical bacterial pneumonia (S. pneumoniae, H. influenzae), amoxicillin 90 mg/kg/day in 2 doses is preferred 1. Azithromycin can be added if atypical pathogens cannot be excluded clinically or radiographically 1.
Clinical Decision Algorithm
Age ≥5 years with lower respiratory tract infection:
Presumed bacterial pneumonia (lobar consolidation, high fever, elevated WBC):
- First-line: Amoxicillin 90 mg/kg/day (max 4 g/day)
- Add azithromycin if atypical features present
Presumed atypical pneumonia (gradual onset, dry cough, interstitial pattern):
- Azithromycin monotherapy as above
Indeterminate presentation:
- Combination therapy with β-lactam + macrolide 1
Important Caveats
Dosing Cap
Critical: The FDA label explicitly states "doses for oral therapy should not exceed adult doses" 1, 2. For a 60-kg child, calculated doses would be 600 mg day 1 and 300 mg days 2-5, but these should be capped at adult maximum doses of 500 mg and 250 mg respectively.
Safety Monitoring
- QT prolongation risk: Higher with medium doses (10-30 mg/kg/day) versus low doses (≤10 mg/kg/day): 82.0% vs 1.2% 3
- Gastrointestinal effects: Most common adverse events are diarrhea and vomiting (47.7% of ADRs) 3
- Monitor for cardiac symptoms, especially if concurrent medications that prolong QT interval
Treatment Duration
The 5-day regimen is specifically validated for community-acquired pneumonia 2. The 3-day regimen (10 mg/kg daily × 3 days) is FDA-approved for acute bacterial sinusitis and otitis media but effectiveness has not been established for pneumonia in pediatric patients 2.
Follow-up Assessment
Children should demonstrate clinical improvement within 48-72 hours 1. If no improvement or deterioration occurs, investigate for:
- Treatment failure (consider second-line agents)
- Complications (parapneumonic effusion)
- Alternative diagnoses (tuberculosis, HIV, malnutrition in endemic areas) 4
Alternative Regimens
If azithromycin is not appropriate: